Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/23/2014 | US8916751 Control of AAD dicot volunteers in monocot crops |
12/23/2014 | US8916750 Barley endosperm promoter |
12/23/2014 | US8916749 Isopentenyl transferase sequences and methods of use |
12/23/2014 | US8916748 Nucleic acid molecules encoding polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII |
12/23/2014 | US8916747 Generation of plants with altered protein, fiber, or oil content |
12/23/2014 | US8916746 Drought tolerant plants and related constructs and methods involving genes encoding DTP21 polypeptides |
12/23/2014 | US8916745 Plant CO2 sensors, nucleic acids encoding them, and methods for making and using them |
12/23/2014 | US8916743 Method for assessment of potential for development of dravet syndrome and use thereof |
12/23/2014 | US8916698 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of DNA |
12/23/2014 | US8916697 Nucleic acid complexes |
12/23/2014 | US8916696 Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use |
12/23/2014 | US8916688 Insecticidal protein, gene encoding the same and uses thereof |
12/23/2014 | US8916687 Insecticidal protein, gene encoding the same and uses thereof |
12/23/2014 | US8916684 Bioengineered protein pores |
12/23/2014 | US8916534 Methods of inducing insulin production |
12/23/2014 | US8916532 Methods for enhancing utrophin production via inhibition of microRNA |
12/23/2014 | US8916531 Modulation of CD40 expression |
12/23/2014 | US8916530 Individualized cancer therapy |
12/23/2014 | US8916529 Oligonucleotide-containing pharmacological compositions and their use |
12/23/2014 | US8916503 Methods and materials using signaling probes |
12/23/2014 | US8916379 Mammalian alpha-kinase proteins, nucleic acids and diagnostic and therapeutic uses thereof |
12/23/2014 | US8916378 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulations of angiogenesis and anticancer therapy |
12/23/2014 | US8916377 Root-preferred promoter and methods of use |
12/23/2014 | US8916376 Metal-binding peptides |
12/23/2014 | US8916371 Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof |
12/23/2014 | US8916370 Isoprene synthase variants for improved microbial production of isoprene |
12/23/2014 | US8916369 Trichoderma reesei α-amylase is a maltogenic enzyme |
12/23/2014 | US8916368 Lipases and uses thereof |
12/23/2014 | US8916365 Expression of cytosolic malic enzyme in transgenic Yarrowia to increase lipid production |
12/23/2014 | US8916361 Elongase gene and uses thereof |
12/23/2014 | US8916358 Methods for control of flux in metabolic pathways through protease manipulation |
12/23/2014 | US8916355 Pain signaling molecules |
12/23/2014 | US8916353 Circovirus sequences associated with piglet weight loss disease (PWD) |
12/23/2014 | US8916350 Compositions and methods for representational selection of nucleic acids from complex mixtures using hybridization |
12/23/2014 | US8916176 Modified parvovirus having enhanced anti-tumor efficacy |
12/23/2014 | US8916174 HIV DNA vaccine regulated by a caev-derived promoter |
12/23/2014 | US8916172 MVA expressing modified HIV envelope, gag, and pol genes |
12/18/2014 | US20140373199 Polypeptides Having Beta-Xylosidase Activity and Polynucleotides Encoding Same |
12/18/2014 | US20140373198 Plant genes involved in nitrate uptake and metabolism |
12/18/2014 | US20140373197 Dsrna as insect control agent |
12/18/2014 | US20140373196 Method to trigger rna interference |
12/18/2014 | US20140373195 Axmi345 delta-endotoxin gene and methods for its use |
12/18/2014 | US20140373194 METHOD AND CONSTRUCTS FOR DELIVERING DOUBLE STRANDED RNA tO PEST ORGANISMS |
12/18/2014 | US20140373193 Use of OsPP18 Gene in Controlling Rice Drought Resistance |
12/18/2014 | US20140373192 High efficiency plant expression promotor from capcicum annuum serine hydroxymethyl transferase gene and uses thereof |
12/18/2014 | US20140373191 Soybean transgenic event mon87751 and methods for detection and use thereof |
12/18/2014 | US20140373190 Transgenic brassica event mon 88302 and methods of use thereof |
12/18/2014 | US20140373189 Hybrid tomato 'e2134649' |
12/18/2014 | US20140373188 Compositions for rna interference and methods of use thereof |
12/18/2014 | US20140373186 Non human animal model for ulcerative colitis and its main complications |
12/18/2014 | US20140371477 Production of dihydrosterculic acid and derivatives thereof |
12/18/2014 | US20140371440 Single-stranded antimicrobial oligonucleotides and uses thereof |
12/18/2014 | US20140371439 Double-stranded rna compounds to casp2 and uses thereof |
12/18/2014 | US20140371432 Novel oligonucleotide conjugates and use thereof |
12/18/2014 | US20140371302 Modified mrnas encoding cell-penetrating polypeptides |
12/18/2014 | US20140371301 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2 |
12/18/2014 | US20140371300 Pharmaceutical composition for treating cancer |
12/18/2014 | US20140371299 Use of Apoptosis-Specific elF-5A siRNA to Down Regulate Expression of Proinflammatory Cytokines to Treat Sepsis |
12/18/2014 | US20140371298 Prevention and treatment of nosema disease in bees |
12/18/2014 | US20140371297 Anti-connexin compounds targeted to connexins and methods of use thereof |
12/18/2014 | US20140371296 Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (malat-1) expression |
12/18/2014 | US20140371295 Methods and compositions to protect aquatic invertebrates from disease |
12/18/2014 | US20140371294 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities |
12/18/2014 | US20140371293 Amine Cationic Lipids and Uses Thereof |
12/18/2014 | US20140371155 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof |
12/18/2014 | US20140371154 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof |
12/18/2014 | US20140371137 Preparation of pna-6-aminoglucosamine conjugates as antiviral agents |
12/18/2014 | US20140371107 Biomolecule isolation |
12/18/2014 | US20140371100 Method of nucleic acid amplification |
12/18/2014 | US20140371085 T cell receptor display |
12/18/2014 | US20140370618 Nucleic acid molecule having binding affinity to rodent-derived igg antibody, binder, detection reagent, and detection kit |
12/18/2014 | US20140370603 Transgenic cells with increased plastoquinone levels and methods of use |
12/18/2014 | US20140370602 Trophectodermal cell-specific gene transfer methods |
12/18/2014 | US20140370597 Rna interference for the treatment of gain-of-function disorders |
12/18/2014 | US20140370590 Purification of Nucleic Acids |
12/18/2014 | US20140370575 Genetically enhanced cyanobacteria for the production of a first chemical compound harbouring zn2+, co2+ or ni2+ -inducible promoters |
12/18/2014 | US20140370573 Method for producing isopropanol and recombinant yeast capable of producing isopropanol |
12/18/2014 | US20140370568 Specialized (iso)eugenol-4-O-methyltransferases (s-IEMTs) and Methods of Making and Using the Same |
12/18/2014 | US20140370561 Genetically modified clostridium thermocellum engineered to ferment xylose |
12/18/2014 | US20140370558 Modifying soybean oil composition through targeted knockout of the fad2-1a/1b genes |
12/18/2014 | US20140370557 Genetically engineered microbes and methods for producing 4-hydroxycoumarin |
12/18/2014 | US20140370546 Protease Deficient Filamentous Fungal Cells and Methods of Use Thereof |
12/18/2014 | US20140370543 Expression Process |
12/18/2014 | US20140370537 Method of inducing differentiation from pluripotent stem cells to skeletal muscle cells |
12/18/2014 | US20140370508 A method of preparing biological material |
12/18/2014 | US20140370500 Nonviral targeted nanoparticle system for gene transfer and drug delivery |
12/18/2014 | US20140370497 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
12/18/2014 | US20140370146 Bile resistant bacillus composition |
12/18/2014 | US20140370079 Method for targeting vascular rhoj for inhibiting tumor angiogenesis |
12/18/2014 | US20140370057 Attenuated live bacteria with increased acid resistance and methods of use thereof |
12/18/2014 | US20140370045 Use of the cd2 signaling domain in second-generation chimeric antigen receptors |
12/18/2014 | US20140370034 SDF-1 Binding Nucleic Acids and the Use Thereof |
12/18/2014 | US20140370027 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis |
12/18/2014 | US20140370009 Therapeutic nanoparticles and methods of use thereof |
12/18/2014 | US20140369999 Screening method |
12/18/2014 | US20140369980 Methods and compositions for targeted cleavage and recombination |
12/18/2014 | US20140369977 Targeting Tumor Neovasculature with Modified Chimeric Antigen Receptors |
12/18/2014 | US20140369967 Method of expanding hematopoietic stem cells |
12/18/2014 | US20140369963 Methods for the treatment of hepatitis b and hepatitis d infections |
12/18/2014 | US20140369962 Methods for the treatment of hepatitis b and hepatitis d infections |